BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33045317)

  • 21. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma.
    Xu Y; Yao Y; Jiang X; Zhong X; Wang Z; Li C; Kang P; Leng K; Ji D; Li Z; Huang L; Qin W; Cui Y
    J Exp Clin Cancer Res; 2018 Apr; 37(1):81. PubMed ID: 29642935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linc00261 suppresses growth and metastasis of non-small cell lung cancer via repressing epithelial-mesenchymal transition.
    Liao J; Dong LP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3829-3837. PubMed ID: 31115010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA RUSC1‑AS‑N promotes cell proliferation and metastasis through Wnt/β‑catenin signaling in human breast cancer.
    Zhou P; Liu P; Zhang J
    Mol Med Rep; 2019 Feb; 19(2):861-868. PubMed ID: 30569097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
    Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
    J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KLF5 regulated lncRNA RP1 promotes the growth and metastasis of breast cancer via repressing p27kip1 translation.
    Jia X; Shi L; Wang X; Luo L; Ling L; Yin J; Song Y; Zhang Z; Qiu N; Liu H; Deng M; He Z; Li H; Zheng G
    Cell Death Dis; 2019 May; 10(5):373. PubMed ID: 31073122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
    Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
    Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation.
    Liu T; Wang J; Sun L; Li M; He X; Jiang J; Zhou Q
    Cell Cycle; 2021 Aug; 20(16):1603-1616. PubMed ID: 34313525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and prognostic significance of NKD2 in ovarian cancer.
    Wei W; Zheng L; Gao Y; He M; Yang F
    Jpn J Clin Oncol; 2021 Mar; 51(3):459-468. PubMed ID: 33324989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NKD2 Trigger NF-κB Signaling Pathway and Facilitates Thyroid Cancer Cell Proliferation.
    Ke S; Pan Q; Wang C; Su Z; Li M; Liu X
    Mol Biotechnol; 2023 Nov; 65(11):1846-1856. PubMed ID: 36820951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HOTAIR Knockdown Decreased the Activity Wnt/β-Catenin Signaling Pathway and Increased the mRNA Levels of Its Negative Regulators in Hela Cells.
    Salmerón-Bárcenas EG; Illades-Aguiar B; Del Moral-Hernández O; Ortega-Soto A; Hernández-Sotelo D
    Cell Physiol Biochem; 2019; 53(6):948-960. PubMed ID: 31820855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
    Xu S; Yuan Z; Jiang C; Chen W; Li Q; Chen T
    Adv Sci (Weinh); 2024 Apr; 11(16):e2308531. PubMed ID: 38380551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long Intergenic Non-Coding RNA LINC00922 Aggravates the Malignant Phenotype of Breast Cancer by Regulating the microRNA-424-5p/BDNF Axis.
    Yue X; Wang Z
    Cancer Manag Res; 2020; 12():7539-7552. PubMed ID: 32904382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway.
    Ge XS; Ma HJ; Zheng XH; Ruan HL; Liao XY; Xue WQ; Chen YB; Zhang Y; Jia WH
    Cancer Sci; 2013 Dec; 104(12):1675-82. PubMed ID: 24118380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway.
    Qiao K; Ning S; Wan L; Wu H; Wang Q; Zhang X; Xu S; Pang D
    J Exp Clin Cancer Res; 2019 Oct; 38(1):418. PubMed ID: 31623640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNATCF7 up-regulates DNMT1 mediated by HPV-18 E6 and regulates biological behavior of cervical cancer cells by inhibiting miR-155.
    Chen YZ; Wang JW; Meng FC; Yang P; Zhang XG; Wu HZ
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8779-8787. PubMed ID: 31696464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of lncRNA PANDAR reduces cell proliferation, cell invasion and suppresses EMT pathway in breast cancer.
    Li Y; Su X; Pan H
    Cancer Biomark; 2019; 25(2):185-192. PubMed ID: 31104011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.